![]() | Yahoo! Health - My Alerts - Edit Alert |
Wednesday, Feb 13, 2013 03:11 AM EST | |
Diabetes treatment Wed, 13 Feb, 2013 12:08 AM PST In a recently published study, researchers from the UCSD School of Medicine and scientists from the San Diego-based biotech company Viacyte, Inc. investigated methods to create endocrine cells, specifically pancreatic T-cells, which are important in treating diabetes through their production of insulin. The study compared two methods of generating endocrine cells from stem cells, in [...] American Diabetes Wholesale Becomes A Major Sponsor For âDownhill For Diabetesâ Fund Raising Event prweb.com Wed, 13 Feb, 2013 12:02 AM PST American Diabetes Wholesale announced that they have become a major sponsor for the âDownhill For Diabetesâ fundraiser for the second year in a row.Pompano Beach, FL (PRWEB) February 13, 2013 American Diabetes Wholesale announced that they have become a major sponsor for the âDownhill For Diabetesâ fundraiser for the second year in a row. The event, held at Pico Mountain Resort, in Killington ... Volunteer from Capital High wins national award Tue, 12 Feb, 2013 09:35 PM PST By CHARLOTTE FERRELL SMITHDAILY MAIL STAFFJay Haapala, a 15-year-old Capital High School freshman, has won a national award for volunteerism.His work with the Juvenile Diabetes Research Foundation won a Prudential Spirit of Community Award. The nationw... Diabetes: city at high risk Tue, 12 Feb, 2013 09:33 PM PST A quarter of Maduraiâs population is diabetic, say doctors Novo Nordisk says FDA rejects insulin drugs Tue, 12 Feb, 2013 08:27 PM PST Novo Nordisk says FDA rejects insulin drugs NEW YORK (AP) â" Novo Nordisk AS says the Food and Drug Administration rejected its applications for approval of once-per-day insulin drugs to treat diabetes. The Danish drugmaker says it received a "complete response letter" from the FDA regarding its applications for approval of Tresiba and Ryzodeg, or insulin degludec, on Friday. | |
|
No comments:
Post a Comment